The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation
Open Access
- 15 July 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 96 (2), 554-559
- https://doi.org/10.1182/blood.v96.2.554
Abstract
Triggering of the tissue factor (TF)-dependent coagulation pathway is considered to underlie the generation of a procoagulant state during endotoxemia. To determine the in vivo pattern of monocytic TF messenger RNA (mRNA) expression during endotoxemia, 10 healthy volunteers were injected with lipopolysaccharide (LPS, 4 ng/kg) and blood was collected before and 0.5, 1, 2, 3, 4, 6, 8, and 24 hours after LPS administration. Total blood RNA was isolated and amplified by NASBA (nucleic acid sequence-based amplification), followed by quantitation of TF mRNA by an electrochemiluminescence (ECL) assay. To compare the pattern of coagulation activation with the kinetics of monocytic TF mRNA expression, we measured plasma levels of markers of thrombin generation, thrombin-antithrombin (TAT) complexes, and prothrombin fragment 1 + 2 (F1 + 2). Baseline value (mean ± SEM) of the number of TF mRNA molecules per monocytic cell was 0.08 ± 0.02. A progressive and significant (P < .0001) increase in TF expression was observed after LPS injection (+0.5 hour: 0.3 ± 0.1, +1 hour: 1.3 ± 0.9, +2 hours: 4.1 ± 0.9), peaking at +3 hours (10 ± 1.9 TF mRNA molecules per monocyte). As TF mRNA levels increased, thrombin generation was augmented. Peak levels of TAT and F1 + 2 were reached later (at t +4 hours) than those of TF mRNA. TF mRNA, TAT, and F1 + 2 levels returned to baseline after 24 hours. In conclusion, we used a NASBA/ECL-based technique to quantify TF mRNA in whole blood during human endotoxemia and observed a 125-fold increase in TF mRNA levels. Our data demonstrate a pivotal role for enhanced TF gene activity in the activation of coagulation after LPS challenge.Keywords
This publication has 38 references indexed in Scilit:
- Comparison of Plasma Tissue Factor Levels in Unstable and Stable Angina PectorisThe American Journal of Cardiology, 1998
- EFFECTS OF CORONARY ANGIOPLASTY ON MONOCYTE TISSUE FACTOR RESPONSE IN PATIENTS WITH STABLE OR UNSTABLE ANGINAThrombosis Research, 1997
- Prevention of Endotoxin-Induced Mortality by Antitissue Factor ImmunizationArchives of Surgery, 1996
- Regulation of the extrinsic pathway system in health and disease: The role of factor VIIa and tissue factor pathway inhibitorThrombosis Research, 1995
- Increased monocyte tissue factor expression in coronary disease.Heart, 1995
- Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.Journal of Clinical Investigation, 1994
- Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.Journal of Clinical Investigation, 1993
- Refractory period phenomenon in the induction of tissue factor expression on endothelial cellsBlood, 1991
- Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathwaysBlood, 1990
- Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin.Molecular and Cellular Biology, 1989